Trials / Conditions / Clinical Stage IIB Gastric Cancer AJCC v8
Clinical Stage IIB Gastric Cancer AJCC v8
6 registered clinical trials studyying Clinical Stage IIB Gastric Cancer AJCC v8.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers NCT05296005 | Ohio State University Comprehensive Cancer Center | Phase 1 |
| Active Not Recruiting | A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma NCT04111172 | Thomas Jefferson University | Phase 2 |
| Completed | Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study NCT04449679 | Thomas Jefferson University | N/A |
| Completed | Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes NCT04501913 | City of Hope Medical Center | — |
| Active Not Recruiting | Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer NCT03776487 | M.D. Anderson Cancer Center | Phase 2 |
| Active Not Recruiting | Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric C NCT03997162 | City of Hope Medical Center | — |